ACUS (Acusphere) Total Tax Payable: $0.00 Mil (As of Sep. 2008)


What is Acusphere Total Tax Payable?

Acusphere ACUS -90.00% Total Tax Payable is $0.00 Mil as of Sep. 2008.

Acusphere's Total Tax Payable for the quarter that ended in Sep. 2008 was $0.00 Mil.

Acusphere Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Acusphere's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acusphere Total Tax Payable Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Total Tax Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Acusphere Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of $0.00 Mil mean?
Acusphere (ACUS) has a Total Tax Payable of $0.00 Mil as of Sep. 2008. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Acusphere and its competitors.
Is Acusphere's Total Tax Payable too high?
Acusphere's current Total Tax Payable is $0.00 Mil.
How does Acusphere's Total Tax Payable compare to CNAB and PIRE?
Acusphere's Total Tax Payable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Acusphere and its competitors. Acusphere's current Total Tax Payable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acusphere stock overvalued right now?
Acusphere (ACUS) has a current Total Tax Payable of $0.00 Mil. The current Total Tax Payable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Acusphere (ACUS), the current Total Tax Payable is $0.00 Mil as of Sep. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acusphere Business Description

Address 99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.